Carlos Panizo Santos-rekin lankidetzan egindako argitalpenak (20)

2017

  1. First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study

    European Journal of Haematology, Vol. 98, Núm. 1, pp. 38-43

2011

  1. Neurologic complications of intrathecal liposomal cytarabine administered prophylactically to patients with non-Hodgkin lymphoma

    Journal of Neuro-Oncology, Vol. 103, Núm. 3, pp. 603-609

2010

  1. Enhanced sensitivity of flow cytometry for routine assessment of minimal residual disease

    Haematologica

2003

  1. Efficacy and safety of bemiparin compared with enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: A randomized, double-blind clinical trial

    Journal of Thrombosis and Haemostasis, Vol. 1, Núm. 3, pp. 425-432

  2. Secondary myelodysplastic syndrome after treatment for promyelocytic leukemia: Clinical and genetic features of two cases

    Cancer Genetics and Cytogenetics, Vol. 143, Núm. 2, pp. 178-181

2002

  1. Acquired inhibitor of the intrinsic pathway in a non-haemophilic patient. Control of bleeding by recombinant factor VIIa [11]

    British Journal of Haematology

2001

  1. Caso clínico: Mujer de 21 años con episodios trombóticos de repetición

    Medicine: Programa de Formación Médica Continuada Acreditado, Vol. 8, Núm. 53, pp. 2863-2865

  2. Inhibidores directos de la trombina: Su papel en el tratamiento de la trombosis arterial y venosa

    Medicina Clinica, Vol. 116, Núm. 2, pp. 63-74

  3. Protocolo diagnóstico y terapéutico de la diátesis trombótica

    Medicine: Programa de Formación Médica Continuada Acreditado, Vol. 8, Núm. 53, pp. 2855-2858

  4. Tratamiento anticoagulante

    Medicine: Programa de Formación Médica Continuada Acreditado, Vol. 8, Núm. 53, pp. 2832-2843

2000

  1. Treatment of venous thromboembolism

    Medicina Clinica, Vol. 115, Núm. 6, pp. 224-235

1999

  1. Markers of fibrinolytic potency and clotting activation in stable angina pectoris: Role of urokinase, assessment of atrioventricular differences and correlation with coronary patency

    Fibrinolysis and Proteolysis, Vol. 13, Núm. 3, pp. 133-138

1998

  1. Acute generalized, widespread bleeding. Diagnosis and management

    Haematologica, Vol. 83, Núm. 11, pp. 1024-1037

  2. Long-term cardiac rehabilitation program favorably influences fibrinolysis and lipid concentrations in acute myocardial infarction

    Haematologica, Vol. 83, Núm. 6, pp. 519-524

1997

  1. Diagnóstico de los estados de hipercoagulabilidad

    Sangre, Vol. 42, Núm. 6, pp. 493-502

  2. The increase of plasminogen activator inhibitor activity is associated with graft occlusion in patients undergoing aorto-coronary bypass surgery

    British Journal of Haematology, Vol. 99, Núm. 2, pp. 262-267

1996

  1. Contribution of cytokines to hyperf ibrinolysis during orthotopic liver transplantation and effect of aprotinin

    Fibrinolysis, Vol. 10, Núm. 5-6, pp. 325-329

  2. Different fibrinolytic profile in orthopedic and abdominal surgery

    Fibrinolysis, Vol. 10, Núm. SUPPL. 3, pp. 132

1995

  1. INHIBIDOR DE LA VIA EXTRINSECA DE LA COAGULACION Y CITOQUINAS EN PACIENTES CON SEPSIS

    Sangre, Vol. 40, Núm. 1, pp. 59-62

1994

  1. Indications for bone marrow transplantation

    Revista de medicina de la Universidad de Navarra, Vol. 38, Núm. 4, pp. 212-225